Ott TR[au] - Search Results

Year	Number of Results
2000	1
2001	1
2002	1
2003	1
2004	3
2005	1
2006	4
2009	2
2010	1
2014	1
2022	0

1

Proteomic profiling of the infective trophozoite stage of Acanthamoeba polyphaga.

Caumo KS, Monteiro KM, Ott TR, Maschio VJ, Wagner G, Ferreira HB, Rott MB. Caumo KS, et al. Among authors: ott tr. Acta Trop. 2014 Dec;140:166-72. doi: 10.1016/j.actatropica.2014.08.009. Epub 2014 Aug 18. Acta Trop. 2014. PMID: 25149354 Free article.

2

Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.

Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R. Pettersson H, et al. Among authors: ott tr. J Med Chem. 2009 Apr 9;52(7):1975-82. doi: 10.1021/jm801534c. J Med Chem. 2009. PMID: 19338356

3

Identification of CC chemokine receptor 7 residues important for receptor activation.

Ott TR, Pahuja A, Nickolls SA, Alleva DG, Struthers RS. Ott TR, et al. J Biol Chem. 2004 Oct 8;279(41):42383-92. doi: 10.1074/jbc.M401097200. Epub 2004 Jul 28. J Biol Chem. 2004. PMID: 15284247 Free article.

4

AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model.

Bradley SR, Lameh J, Ohrmund L, Son T, Bajpai A, Nguyen D, Friberg M, Burstein ES, Spalding TA, Ott TR, Schiffer HH, Tabatabaei A, McFarland K, Davis RE, Bonhaus DW. Bradley SR, et al. Among authors: ott tr. Neuropharmacology. 2010 Feb;58(2):365-73. doi: 10.1016/j.neuropharm.2009.10.003. Epub 2009 Oct 14. Neuropharmacology. 2010. PMID: 19835892

5

The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19.

Ott TR, Lio FM, Olshefski D, Liu XJ, Ling N, Struthers RS. Ott TR, et al. Biochem Biophys Res Commun. 2006 Sep 29;348(3):1089-93. doi: 10.1016/j.bbrc.2006.07.165. Epub 2006 Aug 4. Biochem Biophys Res Commun. 2006. PMID: 16904643

6

A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: Utilization of U937 monocytic cells.

Ott TR, Pahuja A, Lio FM, Mistry MS, Gross M, Hudson SC, Wade WS, Simpson PB, Struthers RS, Alleva DG. Ott TR, et al. J Pharmacol Toxicol Methods. 2005 Mar-Apr;51(2):105-14. doi: 10.1016/j.vascn.2004.10.001. Epub 2004 Nov 5. J Pharmacol Toxicol Methods. 2005. PMID: 15767203

7

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist.

Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J, Del Tredici AL, Piu F, Schiffer HH, Ott TR, Burstein ES, Uldam AK, Thygesen MB, Schlienger N, Andersson CM, Son TY, Harvey SC, Powell SB, Geyer MA, Tolf BR, Brann MR, Davis RE. Vanover KE, et al. Among authors: ott tr. J Pharmacol Exp Ther. 2006 May;317(2):910-8. doi: 10.1124/jpet.105.097006. Epub 2006 Feb 9. J Pharmacol Exp Ther. 2006. PMID: 16469866

8

Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptors.

Burstein ES, Ott TR, Feddock M, Ma JN, Fuhs S, Wong S, Schiffer HH, Brann MR, Nash NR. Burstein ES, et al. Among authors: ott tr. Br J Pharmacol. 2006 Jan;147(1):73-82. doi: 10.1038/sj.bjp.0706448. Br J Pharmacol. 2006. PMID: 16284629 Free PMC article.

9

Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta).

Ott TR, Lio FM, Olshefski D, Liu XJ, Struthers RS, Ling N. Ott TR, et al. Biochemistry. 2004 Mar 30;43(12):3670-8. doi: 10.1021/bi035895h. Biochemistry. 2004. PMID: 15035637

10

Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activation.

Spalding TA, Ma JN, Ott TR, Friberg M, Bajpai A, Bradley SR, Davis RE, Brann MR, Burstein ES. Spalding TA, et al. Among authors: ott tr. Mol Pharmacol. 2006 Dec;70(6):1974-83. doi: 10.1124/mol.106.024901. Epub 2006 Sep 7. Mol Pharmacol. 2006. PMID: 16959945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results